216 related articles for article (PubMed ID: 29624240)
1. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED-FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS.
Yuce M; Capan Y
Acta Pol Pharm; 2017 Mar; 74(2):357-367. PubMed ID: 29624240
[TBL] [Abstract][Full Text] [Related]
2. The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.
Hoppe K; Sznitowska M
AAPS PharmSciTech; 2014 Oct; 15(5):1116-25. PubMed ID: 24871550
[TBL] [Abstract][Full Text] [Related]
3. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method.
Czerwińska K; Mazurek AP
Acta Pol Pharm; 2011; 68(6):831-7. PubMed ID: 22125946
[TBL] [Abstract][Full Text] [Related]
4. Stability-Indicating Liquid Chromatographic Methods with Photodiode Array Detection and Light Scattering Detection for Simultaneous Determination of Candesartan and Hydrochlorothiazide.
de Diego M; Godoy R; Mennickent S; Vergara C; Miranda D; Navarro P
J Chromatogr Sci; 2018 Feb; 56(2):99-107. PubMed ID: 29236956
[TBL] [Abstract][Full Text] [Related]
5. Development of self-microemulsifying bilayer tablets for pH-independent fast release of candesartan cilexetil.
Sohn Y; Lee SY; Lee GH; Na YJ; Kim SY; Seong I; Lee BJ; Kuh HJ; Lee J
Pharmazie; 2012 Nov; 67(11):917-24. PubMed ID: 23210241
[TBL] [Abstract][Full Text] [Related]
6. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection.
Gričar M; Andrenšek S
J Pharm Biomed Anal; 2016 Jun; 125():27-32. PubMed ID: 26999319
[TBL] [Abstract][Full Text] [Related]
7. HPLC method transfer study for simultaneous determination of seven angiotensin II receptor blockers.
Marghany KA; Abdelsalam RA; Haddad GM
J Sep Sci; 2020 Apr; 43(8):1398-1405. PubMed ID: 31991050
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of impurities level of perindopril tert-butylamine in tablets.
Medenica M; Ivanović D; Masković M; Jancić B; Malenović A
J Pharm Biomed Anal; 2007 Sep; 44(5):1087-94. PubMed ID: 17590561
[TBL] [Abstract][Full Text] [Related]
9. Candesartan cilexetil.
Ardiana F; Lestari ML; Indrayanto G
Profiles Drug Subst Excip Relat Methodol; 2012; 37():79-112. PubMed ID: 22469317
[No Abstract] [Full Text] [Related]
10. Voltammetric determination of candesartan cilexetil in its Cu(II) complex and application to pharmaceutical formulations.
Süslü I; Ozaltin N; Altinöz S
J AOAC Int; 2010; 93(2):562-8. PubMed ID: 20480904
[TBL] [Abstract][Full Text] [Related]
11. RP-HPLC analytical method development and optimization for quantification of donepezil hydrochloride in orally disintegrating tablet.
Liew KB; Peh KK; Fung Tan YT
Pak J Pharm Sci; 2013 Sep; 26(5):961-6. PubMed ID: 24035953
[TBL] [Abstract][Full Text] [Related]
12. Solid self-microemulsifying formulation for candesartan cilexetil.
Nekkanti V; Karatgi P; Prabhu R; Pillai R
AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
[TBL] [Abstract][Full Text] [Related]
13. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil.
Mehta S; Shah RP; Priyadarshi R; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):345-54. PubMed ID: 19505786
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil.
Satturwar P; Eddine MN; Ravenelle F; Leroux JC
Eur J Pharm Biopharm; 2007 Mar; 65(3):379-87. PubMed ID: 17123802
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
Emami J; Ghassami N; Ahmadi F
J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
[TBL] [Abstract][Full Text] [Related]
17. Stability indicating LC method for simultaneous determination of irbesartan and hydrochlorothiazide in pharmaceutical preparations.
Rane VP; Patil KR; Sangshetti JN; Yeole RD; Shinde DB
J Chromatogr Sci; 2010 Aug; 48(7):595-600. PubMed ID: 20819286
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a new HPLC analytical method for the determination of alprazolam in tablets.
Pérez-Lozano P; García-Montoya E; Orriols A; Miñarro M; Ticó JR; Suñé-Negre JM
J Pharm Biomed Anal; 2004 Mar; 34(5):979-87. PubMed ID: 15019032
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
Platzer DJ; White BA
J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
[TBL] [Abstract][Full Text] [Related]
20. DEVELOPMENT AND VALIDATION OF FAST REVERSED-PHASE HPLC METHOD FOR ANALYSIS OF ESOMEPRAZOLE IN RABBIT PLASMA.
Muhammad Ranjha N; Rashid Z; Razzaq R; Raza H; Hanif M; Mahmood A
Acta Pol Pharm; 2017 Mar; 74(2):385-391. PubMed ID: 29624243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
